Role of auto- and allotransplantation in B-cell chronic lymphocytic leukemia

2004 ◽  
Vol 18 (4) ◽  
pp. 915-926 ◽  
Author(s):  
Emili Montserrat
Blood ◽  
1999 ◽  
Vol 94 (2) ◽  
pp. 748-753 ◽  
Author(s):  
Claudia Schaffner ◽  
Stephan Stilgenbauer ◽  
Gudrun A. Rappold ◽  
Hartmut Döhner ◽  
Peter Lichter

Abstract Deletion in chromosome bands 11q22-q23 is one of the most common chromosome aberrations in B-cell chronic lymphocytic leukemia (B-CLL). It is associated with extensive lymph node involvement and poor survival. The minimal consensus deletion comprises a segment, which contains the ATM gene presenting an interesting candidate gene, as mutations in ATM predispose A-T patients to lymphoid malignancies. To investigate a potential pathogenic role of ATM in B-cell tumorigenesis, we performed mutation analysis of ATM in 29 malignant lymphomas of B-cell origin (B-CLL = 27; mantle cell lymphoma, [MCL] = 2). Twenty-three of these carried an 11q22-q23 deletion. In five B-CLLs and one MCL with deletion of one ATMallele, a point mutation in the remaining allele was detected, which resulted in aberrant transcript splicing, alteration, or truncation of the protein. In addition, mutation analysis identified point mutations in three cases without 11q deletion: two B-CLLs with one altered allele and one MCL with both alleles mutated. In four cases analyzed, theATM alterations were not present in the germ line indicating a somatic origin of the mutations. Our study demonstrates somatic disruption of both alleles of the ATM gene by deletion or point mutation and thus its pathogenic role in sporadic B-cell lineage tumors.


Blood ◽  
1999 ◽  
Vol 94 (2) ◽  
pp. 748-753 ◽  
Author(s):  
Claudia Schaffner ◽  
Stephan Stilgenbauer ◽  
Gudrun A. Rappold ◽  
Hartmut Döhner ◽  
Peter Lichter

Deletion in chromosome bands 11q22-q23 is one of the most common chromosome aberrations in B-cell chronic lymphocytic leukemia (B-CLL). It is associated with extensive lymph node involvement and poor survival. The minimal consensus deletion comprises a segment, which contains the ATM gene presenting an interesting candidate gene, as mutations in ATM predispose A-T patients to lymphoid malignancies. To investigate a potential pathogenic role of ATM in B-cell tumorigenesis, we performed mutation analysis of ATM in 29 malignant lymphomas of B-cell origin (B-CLL = 27; mantle cell lymphoma, [MCL] = 2). Twenty-three of these carried an 11q22-q23 deletion. In five B-CLLs and one MCL with deletion of one ATMallele, a point mutation in the remaining allele was detected, which resulted in aberrant transcript splicing, alteration, or truncation of the protein. In addition, mutation analysis identified point mutations in three cases without 11q deletion: two B-CLLs with one altered allele and one MCL with both alleles mutated. In four cases analyzed, theATM alterations were not present in the germ line indicating a somatic origin of the mutations. Our study demonstrates somatic disruption of both alleles of the ATM gene by deletion or point mutation and thus its pathogenic role in sporadic B-cell lineage tumors.


Blood ◽  
2002 ◽  
Vol 99 (6) ◽  
pp. 2277-2278 ◽  
Author(s):  
Simona Zupo ◽  
Giovanna Cutrona ◽  
Massimo Mangiola ◽  
Manlio Ferrarini

2005 ◽  
Vol 46 (3) ◽  
pp. 435-442 ◽  
Author(s):  
Luis Martinez-Lostao ◽  
Javier Briones ◽  
Ignasi Forné ◽  
Monica Martinez-Gallo ◽  
Beatriz Ferrer ◽  
...  

Leukemia ◽  
2002 ◽  
Vol 16 (10) ◽  
pp. 2106-2114 ◽  
Author(s):  
P Pérez-Galán ◽  
I Marzo ◽  
P Giraldo ◽  
D Rubio-Félix ◽  
P Lasierra ◽  
...  

2015 ◽  
Vol 112 (37) ◽  
pp. 11636-11641 ◽  
Author(s):  
Francesca Lovat ◽  
Matteo Fassan ◽  
Pierluigi Gasparini ◽  
Lara Rizzotto ◽  
Luciano Cascione ◽  
...  

The central role of the microRNA (miR) 15a/16-1 cluster in B-cell oncogenesis has been extensively demonstrated, with over two-thirds of B-cell chronic lymphocytic leukemia characterized by the deletion of the miR-15a/16-1 locus at 13q14. Despite the well-established understanding of the molecular mechanisms occurring during miR-15a/16-1 dysregulation, the oncogenic role of other miR-15/16 family members, such as the miR-15b/16-2 cluster (3q25), is still far from being elucidated. Whereas miR-15a is highly similar to miR-15b, miR-16-1 is identical to miR-16-2; thus, it could be speculated that both clusters control a similar set of target genes and may have overlapping functions. However, the biological role of miR-15b/16-2 is still controversial. We generated miR-15b/16-2 knockout mice to better understand the cluster’s role in vivo. These mice developed B-cell malignancy by age 15–18 mo with a penetrance of 60%. At this stage, mice showed significantly enlarged spleens with abnormal B cell-derived white pulp enlargement. Flow cytometric analysis demonstrated an expanded CD19+ CD5+ population in the spleen of 40% knockout mice, a characteristic of the chronic lymphocytic leukemia-associated phenotype found in humans. Of note, miR-15b/16-2 modulates the CCND2 (Cyclin D2), CCND1 (Cyclin D1), and IGF1R (insulin-like growth factor 1 receptor) genes involved in proliferation and antiapoptotic pathways in mouse B cells. These results are the first, to our knowledge, to suggest an important role of miR-15b/16-2 loss in the pathogenesis of B-cell chronic lymphocytic leukemia.


2010 ◽  
Vol 9 (1) ◽  
pp. 297 ◽  
Author(s):  
Julie Catusse ◽  
Marion Leick ◽  
Mareike Groch ◽  
David J Clark ◽  
Maike V Buchner ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document